On the evening of December 14, a pharmacist revealed that they had received the medication guide for Pfizer's COVID-19 oral drug Paxlovid (Nirmatrelvir/Ritonavir). The guide was produced by Pfizer's Medical Department and Medical Information Department. The image shows the words "Nirmatrelvir Tablets/Ritonavir Tablets Combination Packaging Medication Guide Officially Launched." The image mainly includes information on the drug’s usage, drug interactions, pharmacokinetics/pharmacodynamics, frequently asked questions, etc., and can be viewed by scanning a QR code. After scanning the code, more detailed information is available regarding indications, dosage, use in special populations, adverse reactions, and more. It also includes relevant pictorial examples and parameter data tables. The aforementioned information can now be accessed on Pfizer's Medical Information website.
